Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the etest, vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methods

Journal of Clinical Microbiology

Volumn 50, Issue 6, 2012, Pages 1852-1855

  Shin, Jong Hee ^a   Kim, Mi Na ^b   Jang, Sook Jin ^c   Ju, Min Young ^a   Kim, Soo Hyun ^a   Shin, Myung Geun ^a   Suh, Soon Pal ^a   Ryang, Dong Wook ^a  

^a Chonnam National University Medical School   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Chosun University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; GLUCOSE; METHYLENE BLUE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA AURIS; CANDIDA HAEMULONII; CANDIDA PSEUDOHAEMULONII; CLINICAL AND LABORATORY STANDARDS INSTITUTE BROTH MICRODILUTION; COMPARATIVE STUDY; CONTROLLED STUDY; EPSILOMETER TEST; EUROPEAN COMMITTEE ON ANTIMICROBIAL SUSCEPTIBILITY TESTING BROTH MICRODILUTION; FUNGAL DETECTION; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENTIATION; VITEK 2 YEAST SUSCEPTIBLITY SYSTEM;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOLOGY;

CANDIDA; CANDIDA HAEMULONII;

EID: 84862060971     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06440-11     Document Type: Article

References (20)

1. Alexander B, et al. 2007. Comparative evaluation of Etest and Sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J. Clin. Microbiol. 45:698-706. (Pubitemid 46427680)
2. Arikan S. 2007. Current status of antifungal susceptibility testing methods. Med. Mycol. 45:569-587. (Pubitemid 350176707)
3. Bourgeois N, et al. 2010. Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods. J. Clin. Microbiol. 48:154-161.
4. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M27-A3, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Cuenca-Estrella M, et al. 2002. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob. Agents Chemother. 46:3644-3647. (Pubitemid 35192943)
6. Cuenca-Estrella M, et al. 2010. Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution reference methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates. J. Clin. Microbiol. 48:1782-1786.
7. Khan ZU, et al. 2007. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. J. Clin. Microbiol. 45:2025-2027. (Pubitemid 46933952)
8. Kim MN, et al. 2009. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin. Infect. Dis. 48:e57-61.
9. Krogh-Madsen M, Arendrup MC, Heslet L, Knudsen JD. 2006. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin. Infect. Dis. 42:938-944.
10. Lee WG, et al. 2011. The first three reported cases of nosocomial fungemia caused by Candida auris. J. Clin. Microbiol. 49:3139-3142.
11. Nguyen MH, et al. 1998. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of prospective study of patients with Candida fungemia. J. Infect. Dis. 177:425-430. (Pubitemid 28063769)
12. Oh BJ, et al. 2011. Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. Med. Mycol. 49:98-102.
13. Park BJ, et al. 2006. Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome. Antimicrob. Agents Chemother. 50:1287-1292.
14. Peyron F, et al. 2001. Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest. J. Clin. Microbiol. 39:339-342. (Pubitemid 32059615)
15. Pfaller MA, Messer SA, Bolmström A. 1998. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B. Diagn. Microbiol. Infect. Dis. 32:223-227. (Pubitemid 29017743)
16. Pfaller MA, et al. 2004. Evaluation of the Etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species. J. Clin. Microbiol. 42:4977-4979. (Pubitemid 39506198)
17. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. 2007. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J. Clin. Microbiol. 45:3522-3528. (Pubitemid 350156842)
18. Rodero L, et al. 2002. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J. Clin. Microbiol. 40:2266-2269. (Pubitemid 34596426)
19. Rodriguez-Tudela JL, et al. 2008. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin. Microbiol. Infect. 14:398-405. (Pubitemid 351356536)
20. Sugita T, Takashima M, Poonwan N, Mekha N. 2006. Candida pseudohaemulonii sp. nov., an amphotericin B- and azole-resistant yeast species, isolated from the blood of a patient from Thailand. Microbiol. Immunol. 50:469-473. (Pubitemid 43927236)